电子提醒与心肌梗死患者流感疫苗接种:三项全国随机临床试验的启示
三项丹麦全国随机临床试验(NUDGE-FLU、NUDGE-FLU-2、NUDGE-FLU-CHRONIC)共纳入2 146 124例随机化个体,评估电子行为提醒对流感疫苗接种的影响。
核心结论
- 在丹麦全国随机临床试验中,强调疫苗接种心血管获益的电子提醒信提高了流感疫苗接种率,且有AMI病史者获益更大。
- 该低成本、可扩展的实施策略应考虑用于促进高危患者的流感疫苗接种。
研究设计与样本
- 三项全国性实施随机临床试验(NUDGE-FLU、NUDGE-FLU-2、NUDGE-FLU-CHRONIC)于2022-2023和2023-2024流感季在丹麦开展。
- 共2 146 124例随机化(平均年龄71.1岁,SD 11.6;女性1 114 725例,占51.9%),其中59 458例(2.8%)有AMI病史。
- 参与者随机接受常规照护或行为学 informed 的电子信件提醒;预设的参与者水平汇总荟萃分析检验AMI状态与提醒效果的交互作用。
临床怎么用
- 对心肌梗死后患者,采用强调疫苗接种心血管获益的电子提醒信可提高流感疫苗接种率。
- 该策略在既往未接种流感疫苗的AMI患者中效果尤为显著,可优先针对该类人群实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Influenza vaccination in patients with acute myocardial infarction (AMI) reduces major adverse cardiac events and is strongly recommended in clinical practice guidelines. Effective strategies to improve vaccination are needed in these high-risk patients. OBJECTIVE: To evaluate whether electronically delivered behavioral nudges improve influenza vaccine uptake in patients with AMI across 3 nationwide implementation randomized clinical trials (RCTs). DESIGN, SETTING, AND PARTICIPANTS: Nationwide Utilization of Danish Government Electronic Letter System for Increasing Influenza Vaccine Uptake (NUDGE-FLU), Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing Influenza Vaccine Uptake Among Older Adults (NUDGE-FLU-2), and Nationwide Utilization of Danish Government Electronic Letter System for Increasing Influenza Vaccine Uptake Among Adults With Chronic Disease (NUDGE-FLU-CHRONIC) were RCTs conducted during the 2022 to 2023 and 2023 to 2024 influenza seasons in Denmark. Participants were randomized to either usual care or various behaviorally informed, electronically delivered, letter-based nudges. In a prespecified participant-level pooled meta-analysis, interaction of AMI status on the effects of letter-based nudges vs usual care was examined. Pooled treatment effects were estimated using binomial regression models with identity link, adjustment for trial, and 2-way clustered SEs at the household and participant levels. Effect modification by recency of AMI as a continuous variable was assessed using restricted cubic spline modeling in NUDGE-FLU-CHRONIC. INTERVENTIONS: Behaviorally informed, electronically delivered, letter-based nudges or usual care. MAIN OUTCOME AND MEASURES: The primary end point was influenza vaccination receipt. RESULTS: Of 2 146 124 individual randomizations (mean [SD] age, 71.1 [11.6] years; 1 114 725 female [51.9%]) across all 3 trials, 59 458 (2.8%) had a history of AMI. Improvement in vaccine uptake was similar in patients with vs without a history of AMI who received any nudge letter compared with usual care (+1.81 vs +1.32 percentage points; P for interaction by AMI status = .09). A letter highlighting the cardiovascular benefits of vaccination (ie, cardiovascular-gain frame) resulted in larger improvements in vaccine uptake among patients with (vs without) a history of AMI (+3.91 vs +2.03 percentage points; P for interaction by AMI status = .002). Among patients with AMI, the benefits of the cardiovascular-gain frame letter were more pronounced in those not vaccinated in the prior season (+13.7 vs +1.48 percentage points; P for interaction <.001). Among younger participants with chronic disease, the cardiovascular-gain frame letter was particularly effective in patients with more recent AMI (P for interaction by continuous recency of AMI <.001). CONCLUSIONS AND RELEVANCE: Across 3 nationwide RCTs of Danish citizens, messaging emphasizing the cardiovascular benefits of vaccination improved influenza vaccination uptake, with greater benefits observed in patients with a history of AMI. This low-cost, scalable implementation strategy should be considered to encourage influenza vaccination in high-risk patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifiers: NCT05542004, NCT06030726, NCT06030739.
引用
- Bhatt, Johansen, Vaduganathan, et al. Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical Trials. JAMA Cardiol. 2025. PMID: 39550717. doi:10.1001/jamacardio.2024.4648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。